Washington / care & cost guideAll desks ↓

Checks / warning signs

What is a reason to pause before paying?

A low price is only part of the offer. Look at the prescription, the source of the medicine and the claims made about it.

What if the offer skips the prescription?

As of September 2026, providing a prescription medicine without a valid order from a licensed person who can prescribe violates federal law.

A checkout screen alone does not answer who assessed you or who issued the prescription. Ask both questions.

What if a compound is called approved or a generic?

A compounded medicine is made to order, rather than supplied as a finished approved drug.

A federal agency reviews medicines: the Food and Drug Administration, usually called FDA.

As of September 2026, the FDA calls it false or misleading to describe a compounded drug as approved, generic or the same as an approved drug.

Generic here means an approved copy of a brand medicine. A pharmacy’s made-to-order medicine belongs to a different product category.

FDA registration, a facility’s listing with the agency, also does not establish approval of its products.

What if an ingredient is labelled for research?

In its July 2026 notice, Washington’s Pharmacy Commission says medicines made for patients cannot contain ingredients labelled “research use only”. It also excludes ingredients marked “not for human consumption”; that label means people must not take them.

The commission’s notice explains the existing rules. It does not approve any particular peptide for patient care.

What if no one answers after the medicine arrives?

FDA consumer guidance flags an online weight-drug service without a licensed doctor available for later questions.

Ask how to get help after the visit before paying. If you do not know the pharmacy’s name, ask for it in writing.

What backs up the answer?

FDA / misleading claims

The FDA calls it misleading to say a made-to-order medicine is approved, a generic copy or proven to produce results matching an approved medicine.

As of September 2026.

Read the FDA’s advertising guidance